Glucosylfingosine (Lyso-GL1) may be the primary biomarker for screening Gaucher disease in Russian patients

Publication date: February 2019Source: Molecular Genetics and Metabolism, Volume 126, Issue 2Author(s): Kirill Savostyanov, Alexander Pushkov, Lubov’ Mura’vova, Goar Movsisyan, Anastasia Rykunova, Rodion Ponomarev, Kira Lukina, Elena Lukina, Leyla Namazova-Baranova
Source: Molecular Genetics and Metabolism - Category: Genetics & Stem Cells Source Type: research